Journal List > J Nutr Health > v.47(3) > 1081335

J Nutr Health. 2014 Jun;47(3):176-185. Korean.
Published online June 30, 2014.  https://doi.org/10.4163/jnh.2014.47.3.176
© 2014 The Korean Nutrition Society
Relationship between flavonoids intake and metabolic syndrome in Korean women with polycystic ovary syndrome
Ji Soo Oh,1 Mi Jin Ahn,1 Chan Jung Han,1 Hyesook Kim,1 Oran Kwon,1 Hye Won Chung,2 and Namsoo Chang1
1Department of Nutritional Science and Food Management, Ewha Womans University, Seoul 120-750, Korea.
2Department of Obstetrics and Gynecology, Ewha Womans University College of Medicine, Seoul 158-710, Korea.

To whom correspondence should be addressed. tel: +82-2-3277-4426, Email: nschang@ewha.ac.kr
Received March 17, 2014; Revised April 03, 2014; Accepted June 03, 2014.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Abstract

Purpose

The purpose of this study was to investigate the relationship between dietary flavonoids intake and metabolic syndrome (MetS) in Korean women with polycystic ovary syndrome (PCOS).

Methods

A total of 223 subjects (mean age; 27.3 ± 4.2 yrs, range; 17-38 yrs) were divided into the MetS group (n = 27) and non-MetS group (n = 196). Dietary intake data were assessed by 24-hour recall method for two non-consecutive days and the average of the two days was used to estimate the usual dietary intake. Dietary habits were assessed using the Mini Dietary Assessment (MDA) score. We analyzed the intakes of six flavonoid classes (anthocyanidins, flavan-3-ols, flavanones, flavones, flavonols, and iso-flavones) using a flavonoids database.

Results

After adjustment for age, total energy intake, alcohol consumption, smok-ing, regular exercise, and oral contraceptive use, dietary flavonols intake was significantly lower in the MetS group (5.1 ± 2.4 mg/d) than in the non-MetS group (8.9 ± 2.8 mg/d) (p = 0.0472). Intakes of other flavonoids except for flavonols did not differ between the two groups. In MDA scores, significant differences were observed only for that related to daily con-sumption of fruit or fruit juice (p = 0.0180). A significant inverse relationship was observed between flavonols intake and the risk of MetS (4th vs. 1st quartile, OR = 0.11, 95% CI = 0.02-0.62, p for trend = 0.0131).

Conclusion

These results sug-gest that higher intake of flavonols may be beneficial for MetS in PCOS women.

Keywords: PCOS; metabolic syndrome; dietary flavonoids intake

Tables


Table 1
General characteristics according to MetS in subjects1)
Click for larger image


Table 2
Blood profiles according to MetS in subjects1)
Click for larger image


Table 3
Dietary plant foods, nutrients and flavonoids intakes according to MetS in subjects1)
Click for larger image


Table 4
Mini dietary assessment (MDA) scores1) of the subjects according to MetS in subjects2)
Click for larger image


Table 5
Odds ratio (OR) and 95% confidence interval (CI) of MetS by quartiles of dietary flavonols intakes1)
Click for larger image

Notes

This research was supported by a fund (2010-E63010-00) by Research of Korea Centers for Disease Control and Prevention and by the Brain Korea 21 Plus.

References
1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89(6):2745–2749.
2. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011;7(4):219–231.
3. Boudreaux MY, Talbott EO, Kip KE, Brooks MM, Witchel SF. Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up. Curr Diab Rep 2006;6(1):77–83.
4. Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W, Lobo R, Norman RJ, Talbott E, Dumesic DA. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab 2010;95(5):2038–2049.
5. Hahn S, Tan S, Sack S, Kimmig R, Quadbeck B, Mann K, Janssen OE. Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2007;115(2):130–135.
6. Cussons AJ, Watts GF, Burke V, Shaw JE, Zimmet PZ, Stuckey BG. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome. Hum Reprod 2008;23(10):2352–2358.
7. Gambineri A, Repaci A, Patton L, Grassi I, Pocognoli P, Cognigni GE, Pasqui F, Pagotto U, Pasquali R. Prominent role of low HDL-cholesterol in explaining the high prevalence of the metabolic syndrome in polycystic ovary syndrome. Nutr Metab Cardiovasc Dis 2009;19(11):797–804.
8. Lee H, Oh JY, Hong Y, Sung YA, Chung H. Prevalence of metabolic syndrome in young Korean women with polycystic ovary syndrome. J Korean Diabetes Assoc 2006;30(4):285–291.
9. Kouki R, Schwab U, Hassinen M, Komulainen P, Heikkilä H, Lakka TA, Rauramaa R. Food consumption, nutrient intake and the risk of having metabolic syndrome: the DR's EXTRA Study. Eur J Clin Nutr 2011;65(3):368–377.
10. Martínez-González MÁ, Martín-Calvo N. The major European dietary patterns and metabolic syndrome. Rev Endocr Metab Disord 2013;14(3):265–271.
11. Almoosawi S, Tsang C, Ostertag LM, Fyfe L, Al-Dujaili EA. Differential effect of polyphenol-rich dark chocolate on biomarkers of glucose metabolism and cardiovascular risk factors in healthy, overweight and obese subjects: a randomized clinical trial. Food Funct 2012;3(10):1035–1043.
12. Barona J, Aristizabal JC, Blesso CN, Volek JS, Fernandez ML. Grape polyphenols reduce blood pressure and increase flow-mediated vasodilation in men with metabolic syndrome. J Nutr 2012;142(9):1626–1632.
13. Sohrab G, Hosseinpour-Niazi S, Hejazi J, Yuzbashian E, Mirmiran P, Azizi F. Dietary polyphenols and metabolic syndrome among Iranian adults. Int J Food Sci Nutr 2013;64(6):661–667.
14. Steffen Y, Gruber C, Schewe T, Sies H. Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch Biochem Biophys 2008;469(2):209–219.
15. Xiao ZP, Peng ZY, Peng MJ, Yan WB, Ouyang YZ, Zhu HL. Flavonoids health benefits and their molecular mechanism. Mini Rev Med Chem 2011;11(2):169–177.
16. Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, Carmina E, Chang J, Yildiz BO, Laven JS, Boivin J, Petraglia F, Wijeyeratne CN, Norman RJ, Dunaif A, Franks S, Wild RA, Dumesic D, Barnhart K. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012;97(1):28–38.e25.
17. Korean Diabetes Association. Treatment guideline for diabetes. the 4th edition. Seoul: Korean Diabetes Association; 2011.
18. The Korean Nutrition Society. Nutritional assessment program 'CAN-Pro 4.0' [CD-ROM]. Seoul: The Korean Nutrition Society; 2011
19. Yang YK, Kim JY, Kwon O. Development of flavonoid database for commonly consumed foods by Koreans. Korean J Nutr 2012;45(3):283–292.
20. Kim WY, Cho MS, Lee HS. Development and validation of mini dietary assessment index for Koreans. Korean J Nutr 2003;36(1):83–92.
21. Edwards RL, Lyon T, Litwin SE, Rabovsky A, Symons JD, Jalili T. Quercetin reduces blood pressure in hypertensive subjects. J Nutr 2007;137(11):2405–2411.
22. Jacques PF, Cassidy A, Rogers G, Peterson JJ, Meigs JB, Dwyer JT. Higher dietary flavonol intake is associated with lower incidence of type 2 diabetes. J Nutr 2013;143(9):1474–1480.
23. Holden JM, Bhagwat SA, Haytowitz DB, Gebhardt SE, Dwyer JT, Peterson J, Beecher GR, Eldridge AL, Balentine D. Development of a database of critically evaluated flavonoids data: application of USDA's data quality evaluation system. J Food Compost Anal 2005;18(8):829–844.
24. Erdman JW Jr, Balentine D, Arab L, Beecher G, Dwyer JT, Folts J, Harnly J, Hollman P, Keen CL, Mazza G, Messina M, Scalbert A, Vita J, Williamson G, Burrowes J. Flavonoids and heart health: proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC. J Nutr 2007;137 3 Suppl 1:718S–737S.
25. Kim JY, Kwon O. Culinary plants and their potential impact on metabolic overload. Ann N Y Acad Sci 2011;1229:133–139.
26. Galleano M, Calabro V, Prince PD, Litterio MC, Piotrkowski B, Vazquez-Prieto MA, Miatello RM, Oteiza PI, Fraga CG. Flavonoids and metabolic syndrome. Ann N Y Acad Sci 2012;1259:87–94.
27. van Dam RM, Naidoo N, Landberg R. Dietary flavonoids and the development of type 2 diabetes and cardiovascular diseases: review of recent findings. Curr Opin Lipidol 2013;24(1):25–33.
28. Siasos G, Tousoulis D, Tsigkou V, Kokkou E, Oikonomou E, Vavuranakis M, Basdra EK, Papavassiliou AG, Stefanadis C. Flavonoids in atherosclerosis: an overview of their mechanisms of action. Curr Med Chem 2013;20(21):2641–2660.
29. Landberg R, Sun Q, Rimm EB, Cassidy A, Scalbert A, Mantzoros CS, Hu FB, van Dam RM. Selected dietary flavonoids are associated with markers of inflammation and endothelial dysfunction in U.S. women. J Nutr 2011;141(4):618–625.
30. Coskun O, Kanter M, Korkmaz A, Oter S. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Pharmacol Res 2005;51(2):117–123.
31. Mahesh T, Menon VP. Quercetin allievates oxidative stress in streptozotocin-induced diabetic rats. Phytother Res 2004;18(2):123–127.
32. Kobori M, Masumoto S, Akimoto Y, Takahashi Y. Dietary quercetin alleviates diabetic symptoms and reduces streptozotocin-induced disturbance of hepatic gene expression in mice. Mol Nutr Food Res 2009;53(7):859–868.
33. Vessal M, Hemmati M, Vasei M. Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp Biochem Physiol C Toxicol Pharmacol 2003;135C(3):357–364.
34. Yang YK. In: Construction of flavonoid database for the estimation of flavonoid intake in Korean [Dissertation]. Seoul: Ewha Womans University; 2011.
35. Yoo S, Nicklas T, Baranowski T, Zakeri IF, Yang SJ, Srinivasan SR, Berenson GS. Comparison of dietary intakes associated with metabolic syndrome risk factors in young adults: the Bogalusa Heart Study. Am J Clin Nutr 2004;80(4):841–848.
36. Yang YJ, Kim YJ, Yang YK, Kim JY, Kwon O. Dietary flavan-3-ols intake and metabolic syndrome risk in Korean adults. Nutr Res Pract 2012;6(1):68–77.
37. U.S. Department of Health and Human Services. U.S. Department of Agriculture. Dietary guidelines for Americans 2005. 6th edition. Washington, D.C.: U.S. Government Printing Office; 2005.
38. Estaquio C, Castetbon K, Kesse-Guyot E, Bertrais S, Deschamps V, Dauchet L, Péneau S, Galan P, Hercberg S. The French National Nutrition and Health Program score is associated with nutritional status and risk of major chronic diseases. J Nutr 2008;138(5):946–953.
39. World Cancer Research Fund. American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington D.C.: American Institute for Cancer Research; 2007.
40. Lee HS, Cho YH, Park J, Shin HR, Sung MK. Dietary intake of phytonutrients in relation to fruit and vegetable consumption in Korea. J Acad Nutr Diet 2013;113(9):1194–1199.
41. The Korean Nutrition Society. Dietary reference intakes for Koreans. 1st revision. Seoul: The Korean Nutrition Society; 2010.
42. Vural B, Caliskan E, Turkoz E, Kilic T, Demirci A. Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome. Hum Reprod 2005;20(9):2409–2413.
43. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, D'Agostino RB Sr, O'Donnell CJ. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007;116(1):39–48.
44. Ganie MA, Kalra S. Polycystic ovary syndrome - A metabolic malady, the mother of all lifestyle disorders in women - Can Indian health budget tackle it in future? Indian J Endocrinol Metab 2011;15(4):239–241.